Intellipharmaceutics International Inc. (IPCI)

[cysonic]

The reason for the cancellation is the missing final PODRAS patent issue. Odidi just cannot explain a technology that isn't finally protected. Have a look at the originally planned content:



So let's stop the speculations and hope for a fast revision by the U.S. Patent and Trademark office. It's already 6 weeks since the allowance was given - see here:

http://portal.uspto.gov/pair/PublicPair

Application Number: 14/790,101

Transaction History:

09-08-2016 Mailing Corrected Notice of Allowability

So with the final issuance the "real game" can begin. We just need a little bit more patience. And don't forget: Profit lies in purchasing... Now that some investors lose patience, one might add as long as the price is still so cheap. Market cap $84 million now. That's the potential quarterly (!) revenue next year, if Rexista gets approved! And PODRAS alone might be valued a multiple of the current market cap.

Sometimes it's hard to wait. But that's all we and IPCI can do at the moment.